ArticleThe Lancet. Infectious diseases2021
Increasing clindamycin resistance in group A streptococcus.
Article in The Lancet. Infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 32 citations in OpenAlex.
- DetectingAntibiotics (Basel, Switzerland) · 2026Article
- Meningitis and subdural empyema caused by group A streptococcal infection.BMC pediatrics · 2026Article
- Impact of beta-lactam allergy labels on antibiotic prophylaxis and surgical site infections after cesarean section; a retrospective study.Antimicrobial resistance and infection control · 2026Article
- Molecular epidemiology and antimicrobial susceptibility of group A Streptococcus isolated from children in Greece during 2023.Infection · 2026Article
- Antibiotic Prophylaxis in Patients Undergoing Oncologic Head and Neck Surgery with Free Flap Reconstruction: Still a Matter of Debate.Antibiotics (Basel, Switzerland) · 2025Review
- Invasive Group A Streptococcal Infection in Children, 1992-2023.JAMA network open · 2025Article
- Streptococcal Toxic Shock Syndrome: Diagnostic and Therapeutic Approaches Incorporating Point-of-Care Antigen Testing-Case Series.Clinics and practice · 2025Article
- Global spread of Streptococcus pyogenes A genomics-supported narrative review.FEMS microbiology reviews · 2025Review
- Risk factors for surgical site infection following hysterectomy: nine-year experience at a large safety-net hospital network in New York City.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2025Article
- Evaluation of outpatient clindamycin prescriptions across a large military healthcare network.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2025Article
- [Necrotizing soft tissue infections].Die Anaesthesiologie · 2024Review
- Dihydrothiazolo ring-fused 2-pyridone antimicrobial compounds treatScience advances · 2024Article
- Increasing Rate of FatalMicroorganisms · 2024Article
- Impact of Pericoronary Microbiota Composition on Course of Recovery after Third Molar Alveotomy.Life (Basel, Switzerland) · 2024Article
- Rising incidence of severe maxillofacial space infections in Germany.Clinical oral investigations · 2024Article
- Dihydrothiazolo ring-fused 2-pyridone antimicrobial compounds treatbioRxiv : the preprint server for biology · 2024Article
- Ozone adjunct treatment in facing multidrug-resistant bacteria?Clinical case reports · 2023Article
- Acute bacterial lymphadenitis in children: a retrospective, cross-sectional study.European journal of pediatrics · 2023Article
- Development of Adapalene Loaded Liposome Based Gel for Acne.Gels (Basel, Switzerland) · 2023Article
- Clindamycin-resistant Streptococcus pyogenes in Chinese children.The Lancet. Infectious diseases · 2021Article
Corrections and comments
- Commented on by
- Comment on
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.